LGP
BMY icon

Leonard Green & Partners’s Bristol-Myers Squibb BMY Stock Holding History

Leonard Green & Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-700,000
Closed -$41.2M – 30
2020
Q2 		$41.2M Buy
+700,000
New +$41.9M 7.67% 5

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Leonard Green & Partners's BMY Position: Q2 2020 in Review

Leonard Green & Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 70,000 shares — an estimated $4.19M sold.

Leonard Green & Partners first reported a position in BMY in Q4 2019 and held it in 2 quarters. The position peaked at $6.42M in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Leonard Green & Partners reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Leonard Green & Partners sold 70,000 Bristol-Myers Squibb shares in Q2 2020, an estimated $4.19M.
  • Leonard Green & Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 2 quarters.
  • Leonard Green & Partners's Bristol-Myers Squibb position peaked at $6.42M in Q4 2019.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Leonard Green & Partners's 13F filing for Q2 2020, filed 14 Aug 2020.